Case study
Find out how we used a hybrid qual-quant methodology to assess the market opportunity for a new rare disease treatment.
Make the right strategic decisions at the early stages of commercialisation
Product development is the lifeblood of the pharmaceutical industry. But evaluating the wealth of potential opportunities at the early stages of drug discovery and commercialisation is fraught with uncertainty. We can help you to assess and evaluate opportunities systematically and comprehensively, using a range of qualitative research and quantitative research methods to answer questions such as:
Custom research offerings include:
UK Office
Registered in England & Wales No. 3350410 as The Research Partnership Limited
Registered office: Third Floor, 24 Chiswell Street, London, EC1Y 4YX
Directors: Mary Assimakopoulos, Mark Jeffery
VAT No. GB 714 0707 65